STAQ Pharma
Founded 2018 · 118 employees on LinkedIn · 3 known investors
STAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies medications to hospitals and healthcare providers across the United States, aiming to address drug shortages. The company is owned and guided by several healthcare systems and focuses on safety, transparency, availability, and quality.
Also known as STAQ
Founders & leadership
Investors · 3
Company profile
researched Aug 2026STAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies sterile medications to hospitals, health systems and other healthcare providers, positioning its output as a response to drug shortages. The company describes a portfolio of ready-to-use sterile products, including items such as ropivacaine bags and morphine PCAs cited by customers, and publishes a downloadable product catalog for prospective buyers.
Operations are carried out in two FDA-registered facilities that the company states were designed from the ground up to meet CGMP standards, with an emphasis on sterility and dose-level reliability. STAQ frames its work around four stated core values: safety, transparency, availability and quality, the last covering quality control and compliance in 503B manufacturing.
Business model
STAQ Pharma supplies compounded sterile medications to hospital and health-system pharmacies as an outsourcing partner, with customers onboarded through a "become a customer" process and served via an existing customer portal.
Latest developments
The company announced the launch of an oncology product portfolio aimed at critical drug shortages and reported receiving the 2024 Heartbeat of Healthcare Supplier Award.
▸Full profile — market position, technology, go-to-market, geography
Market position
Operates in the 503B outsourced sterile compounding segment, differentiating on hospital ownership and a drug-shortage mitigation focus; a 2024 Heartbeat of Healthcare Supplier Award is cited by the company.
Ownership and guidance by several leading healthcare systems, purpose-built CGMP facilities, and a stated emphasis on transparency in 503B operations and proactive inventory management to maintain supply continuity.
Technology
Compounding of ready-to-use sterile medications in two FDA-registered facilities built to CGMP standards, with quality control processes aimed at sterility and compliance.
Go-to-market
Direct sales to hospitals and health systems, supported by health-system partner/owner relationships, a published product catalog, and online customer onboarding and ordering access.
Hospitals, health systems, hospital and inpatient pharmacies, and pharmacy directors and buyers; named customer references include St. Anthony North Health Campus, Zuckerberg San Francisco General Hospital and Trauma Center, and Madison Health.
Geography
Serves healthcare providers nationwide in the United States from two FDA-registered facilities; referenced customer sites include Colorado, California and Ohio.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsThe company announced an oncology product portfolio intended to address critical drug shortages.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- STAQ Pharmastaqpharma.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does STAQ Pharma do?
- STAQ Pharma is a hospital-backed, FDA-registered 503B outsourcing facility compounding ready-to-use sterile medications.
- Who are STAQ Pharma's investors?
- STAQ Pharma's investors include CU Healthcare Innovation Fund, JobsOhio Ventures, Stout Street Capital.